Baird Financial Group, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1648711
MILWAUKEE, WI
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,950,970
-$11,544,593 QoQ
Shares Held
52,845
-8.2% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#153
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 33%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $221,188,371 across 29 Biotechnology names. REGN ranks #2 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
368,978 | $105,147,660 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
52,845 | $32,950,970 | |
| 3 | INCY |
Incyte Corp
|
224,855 | $25,489,561 | |
| 4 | EXEL |
Exelixis, Inc.
|
437,138 | $23,784,676 | |
| 5 | INVA |
Innoviva, Inc.
|
274,391 | $6,231,419 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
38,672 | $2,880,290 | |
| 7 | ASND |
Ascendis Pharma A/S
|
10,735 | $2,863,239 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
8,550 | $2,702,569 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,950,970 | 52,845 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $44,495,563 | 57,589 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $38,493,156 | 49,870 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,205,996 | 48,386 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $25,713,975 | 48,979 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $28,284,120 | 44,596 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,727,110 | 34,713 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $37,684,850 | 35,848 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $36,463,383 | 34,693 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,659,209 | 33,932 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $29,739,776 | 33,861 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,656,393 | 33,606 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,935,285 | 33,311 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,821,800 | 31,426 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,605,678 | 35,490 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $24,464,528 | 35,514 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $21,868,853 | 36,995 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $25,512,583 | 36,529 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,483,559 | 18,184 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $11,679,973 | 19,300 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,504,887 | 15,227 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $6,041,524 | 12,769 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,094,839 | 8,476 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,498,951 | 8,037 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,818,942 | 7,727 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $3,938,546 | 8,066 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||